Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Pharm ; 14(10): 3568-3576, 2017 10 02.
Artigo em Inglês | MEDLINE | ID: mdl-28829143

RESUMO

Novel "pairs" of drugs possessing pharmacological synergies could be encapsulated into polymeric micelles and exert superb therapeutic effects in vivo upon intravenous administration, with the prerequisite that the micelles remain stable. NADP(H) quinone oxidoreductase 1 (NQO1) inhibitors, such as ß-lapachone (LPC) and tanshinone IIA (THA), are structurally and pharmacologically similar molecules that are poorly water-soluble, crystallize extremely fast, and demonstrate synergistic anticancer effect when used together with paclitaxel (PTX). However, when coencapsulated with PTX in poly(ethylene glycol)-b-poly(d,l-lactic acid) (PEG-PLA) micelles, only PTX/LPC but not the PTX/THA pair yields satisfactory colloidal stability. To reveal the molecular mechanism contributing to the colloidal stability of the coencapsulated micelles, we investigated the molecular interactions of PTX/LPC and PTX/THA, through both experimental methods (crystallization kinetics, 13C NMR) and molecular dynamic simulation. We observed that PTX was capable of inhibiting LPC but not THA crystallization both in an aqueous environment and in the solid state, which could be attributed to the strong hetero-intermolecular interactions (π-π, H-bonding) between LPC and PTX, which disrupted the homo-intermolecular interactions between LPC molecules and thus formed a favorable miscible binary system. In comparison, the lack of a strong PTX/THA interaction left the strong THA/THA stacking interaction undisturbed and the fast THA crystallization tendency unrestrained. We conclude that the intermolecular interactions, i.e., the "pharmaceutical synergy", between the coencapsulated drugs critically control the colloidal stability of polymeric micelles and, therefore, should be evaluated when coencapsulated drug delivery systems are designed for optimal therapeutic benefits.


Assuntos
Antineoplásicos/farmacologia , Portadores de Fármacos/química , Composição de Medicamentos/métodos , NAD(P)H Desidrogenase (Quinona)/antagonistas & inibidores , Abietanos/farmacologia , Química Farmacêutica , Coloides , Cristalização , Sinergismo Farmacológico , Inibidores Enzimáticos , Humanos , Micelas , Simulação de Dinâmica Molecular , Nanopartículas/química , Naftoquinonas/farmacologia , Paclitaxel/farmacologia , Polietilenoglicóis/química
2.
J Biol Chem ; 287(9): 6406-20, 2012 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-22219187

RESUMO

Enterovirus 71 (EV71) is one of the major pathogens that cause hand, foot, and mouth disease outbreaks in young children in the Asia-Pacific region in recent years. Human scavenger receptor class B 2 (SCARB2) is the main cellular receptor for EV71 on target cells. The requirements of the EV71-SCARB2 interaction have not been fully characterized, and it has not been determined whether SCARB2 serves as an uncoating receptor for EV71. Here we compared the efficiency of the receptor from different species including human, horseshoe bat, mouse, and hamster and demonstrated that the residues between 144 and 151 are critical for SCARB2 binding to viral capsid protein VP1 of EV71 and seven residues from the human receptor could convert murine SCARB2, an otherwise inefficient receptor, to an efficient receptor for EV71 viral infection. We also identified that EV71 binds to SCARB2 via a canyon of VP1 around residue Gln-172. Soluble SCARB2 could convert the EV71 virions from 160 S to 135 S particles, indicating that SCARB2 is an uncoating receptor of the virus. The uncoating efficiency of SCARB2 significantly increased in an acidic environment (pH 5.6). These studies elucidated the viral capsid and receptor determinants of enterovirus 71 infection and revealed a possible target for antiviral interventions.


Assuntos
Antígenos CD36/metabolismo , Enterovirus Humano A/crescimento & desenvolvimento , Infecções por Enterovirus/virologia , Proteínas de Membrana Lisossomal/metabolismo , Receptores Depuradores/metabolismo , Proteínas Virais de Fusão/metabolismo , Animais , Antígenos CD36/química , Antígenos CD36/genética , Linhagem Celular Tumoral , Quirópteros , Cricetinae , Enterovirus Humano A/genética , Infecções por Enterovirus/metabolismo , Técnicas de Silenciamento de Genes , Proteínas de Fluorescência Verde/genética , Células HEK293 , Humanos , Rim/citologia , Proteínas de Membrana Lisossomal/química , Proteínas de Membrana Lisossomal/genética , Camundongos , Estrutura Terciária de Proteína , Receptores Depuradores/química , Receptores Depuradores/genética , Rabdomiossarcoma , Proteínas Virais de Fusão/genética
3.
ChemSusChem ; 16(12): e202300015, 2023 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-36905229

RESUMO

With a view to using solar energy, the exploitation of near-infrared (NIR) light, which constitutes about 50 % of solar energy, in photocatalytic H2 O2 synthesis remains challenging. In this study, resorcinol-formaldehyde (RF), which has a relatively low bandgap and high conductivity, is introduced for photothermal catalytic generation of H2 O2 under ambient conditions. Owing to the promoted surface charge transfer rate under high temperature, the photosynthetic yield reaches roughly 2000 µm within 40 min under 400 mW cm-2 irradiation with a solar-to-chemical conversion (SCC) efficiency of up to 0.19 % at 338 K under ambient conditions, exceeding the rate of photocatalysis with a cooling system by a factor of about 2.5. Notably, the H2 O2 produced by RF during photothermal process was formed via a two-channel pathway, leading to the overall promotion of H2 O2 formation. The resultant H2 O2 can be applied in situ for pollutant removal. This work offers a sustainable and economical route for the efficient formation of H2 O2 .


Assuntos
Energia Solar , Fotossíntese , Catálise , Condutividade Elétrica , Formaldeído , Polímeros
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA